FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Guide on Covid Effects on Device User Fee Activities

FDA issues a guidance on Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices Questions a...

Medical Devices

Guide on Notifying CDRH on Discontinued Products

FDA updates a guidance entitled Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD...

Medical Devices

FDA Troubled by Chinese Firms Using Fictitious U.S. Agent

FDA faces another Covid-19 debacle as it deals with over 1,300 Chinese firms providing medical protective equipment that registered in FDAs database w...

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 6/21/2020.

Medical Devices

FDA OKs Expansion of Obesity Study

FDA approves the expansion of a USGI Medical pilot study of it obesity-treating endoscopic procedure known as POSE 2.0.

Human Drugs

Mylan Urges Faster ANDA Approval for MS Generic

Mylan says it is urging FDA to speed up its review of the companys ANDA for a generic copy of Biogens multiple sclerosis (MS) drug Tecfidera (dimethyl...

Human Drugs

Guide on GMP Considerations Due to Infected Employee

FDA posts a guidance entitled Good Manufacturing Practice Considerations for Responding to Covid-19 Infection in Employees in Drug and Biological Prod...

Federal Register

Oncologic Panel to Review GSK Myeloma BLA

Federal Register notice: FDA announces a 7/14 online/teleconferencing Oncologic Drugs Advisory Committee meeting that will review a GlaxoSmithKline BL...

Federal Register

Notice Corrected on ANDAs Withdrawn

Federal Register notice: FDA corrects a 2/12/2019 notice that announced the withdrawal of approval of 12 ANDAs from multiple applicants.

Medical Devices

FDA OKs Dupixent Pre-filled Pen for At-Home Use

FDA approves a 300 mg single-dose pre-filled pen for Regeneron Pharmaceuticals and Sanofis Dupixent (dupilumab).